Quote this publication Share Print

ACTILYSE

-
Opinions on drugs - Posted on Jan 13 2011

Reason for request

Inclusion on list of products for hospital use.

-


Actual benefit

Important

The actual benefit of ACTILYSE 2 mg is substantial.


Improvement in actual benefit

IV (mineur)

ACTILYSE 2 mg provides a minor improvement in actual benefit (IAB IV) in terms of efficacy in comparison with ACTOSOLV UROKINASE.


Contact Us

Évaluation des médicaments

See also

All our publication